INDIANAPOLIS (WISH) — One of Indiana’s biggest companies, Indianapolis-based drugmaker Eli Lilly and Company, is pulling much of its business out of Russia because of its war with Ukraine.
Lilly announced on Tuesday that it had “suspended all investments, promotional activities and new clinical trials in Russia, as well as the export of non-essential drugs to [Russia].”
In a statement, the company explained its decision, saying, “We have an ethical and moral obligation to help alleviate human suffering.”
Tim Fort, a professor of business ethics at Indiana University, told I-Team 8 that the struggle for economic power has been the biggest advantage companies have over Russia.
“Sometimes an event happens that speaks to them as human beings, and they’ll say, ‘You know, we’re not doing this, we’re taking a stand,'” Fort said.
Fort adds that making these kinds of decisions isn’t always easy.
“From a pure and perfect ethical standpoint to say, you know, the greater good is going to be for us to get out of this now, find safer ways to deliver these products long term, and get out of there,” Fort said.
Although it is withdrawing non-essential drugs from the Russian market, Lilly says it will still supply certain drugs to the Russian people.
“Our operations in Russia are now solely focused on ensuring people with conditions such as cancer and diabetes continue to get the Lilly medicines they need,” Lilly said in a statement. “If we generate profits from our sales in Russia, we will donate them to organizations dedicated to humanitarian aid. We hope for an immediate end to hostilities and a resolution of this crisis as soon as possible.